Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: clot (144), thicken (24), coalesce (1), set (912)

Bevacizumab ver 1

Description: Chemotherapy Protocol CNS CANCER BEVACIZUMAB This protocol may require funding. This is an unlicensed indication for bevacizumab. Regimen CNS-Bevacizumab Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Bevacizumab-ver-1.pdf

Bevacizumab (15mgkg)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15) This protocol may require funding Regimen Ovary-Bevacizumab (15) Indication Recurrent platinum sensitive ovarian, peritoneal
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Bevacizumab15mgkg.pdf

Bevacizumab(15mgkg) Carboplatin Gemcitabine (day1)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15)-CARBOPLATIN (AUC4)-GEMCITABINE (day 1) This protocol may require funding Regimen • Ovary-Bevacizumab (15)-Carboplatin
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Bevacizumab15mgkg-Carboplatin-Gemcitabine-day1.pdf

Bevacizumab (15) Carboplatin-Paclitaxel (21 day)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15)-CARBOPLATIN (AUC5)-PACLITAXEL (21 day) Regimen • Cervix-Bevacizumab (15)-Carboplatin (AUC5)-Paclitaxel (21 day) Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Cervical-cancer/Bevacizumab-15-Carboplatin-Paclitaxel-21-day.pdf

Lenalidomide

Description: Chemotherapy Protocol MULTIPLE MYELOMA LENALIDOMIDE Regimen • Multiple Myeloma – Lenalidomide Indication • Lenalidomide is recommended, within its licensed indication, as an option for
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Lenalidomide.pdf

Bevacizumab-Irinotecan Ver 1.1

Description: Chemotherapy Protocol COLORECTAL CANCER BEVACIZUMAB-IRINOTECAN This protocol may require funding Regimen Colorectal Cancer – Bevacizumab-Irinotecan Indication First line treatment of
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Bevacizumab-IrinotecanVer11.pdf

Bevacizumab-Fluorouracil-Folinic Acid-Oxaliplatin

Description: Chemotherapy Protocol COLORECTAL CANCER BEVACIZUMAB-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)OXALIPLATIN This regimen may require funding Regimen • Colorectal Cancer – Bevacizumab
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Bevacizumab-Fluorouracil-FolinicAcid-Oxaliplatin.pdf

Bevacizumab-Fluorouracil-Folinic Acid-Irinotecan

Description: Chemotherapy Protocol COLORECTAL CANCER BEVACIZUMAB-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)IRINOTECAN This regimen may require funding Regimen • Colorectal Cancer – Bevacizumab
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Bevacizumab-Fluorouracil-FolinicAcid-Irinotecan.pdf

Bevacizumab-Capecitabine

Description: Chemotherapy Protocol COLORECTAL CANCER BEVACIZUMAB-CAPECITABINE This protocol may require funding Regimen • Colorectal Cancer– Bevacizumab-Capecitabine Indication • The first line treatment
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Bevacizumab-Capecitabine.pdf

Aflibercept-Fluorouracil-Folinic Acid-Irinotecan

Description: Chemotherapy Protocol COLORECTAL CANCER AFLIBERCEPT-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)IRINOTECAN This regimen may require funding Regimen • Colorectal Cancer – Aflibercept
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Aflibercept-Fluorouracil-Folinic-Acid-Irinotecan.pdf

1 to 10 of 25

Previous 1 2 3 Next